{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:23:05Z","timestamp":1769844185211,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015693","name":"Research Institute for Gastroenterology and Liver Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["RIGLD 1090"],"award-info":[{"award-number":["RIGLD 1090"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.diagmicrobio.2025.117184","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T21:04:55Z","timestamp":1762463095000},"page":"117184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of sub-minimum inhibitory concentrations of metronidazole, vancomycin, and fidaxomicin on growth rate and virulence of Clostridioides difficile"],"prefix":"10.1016","volume":"114","author":[{"given":"Masoumeh","family":"Azimirad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Noori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi Azizmohammad","family":"Looha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahalieyah","family":"Anantharajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Zali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-7581","authenticated-orcid":false,"given":"Abbas","family":"Yadegar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.117184_bib0001","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrgastro.2016.25","article-title":"Clostridium difficile infection: epidemiology, diagnosis and understanding transmission","volume":"13","author":"Martin","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.20","article-title":"Clostridium difficile infection","volume":"2","author":"Smits","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0003","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1586\/14787210.2014.866515","article-title":"Clostridium difficile infection: molecular pathogenesis and novel therapeutics","volume":"12","author":"Rineh","year":"2014","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0004","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fpubh.2020.00293","article-title":"Risk factors for primary Clostridium difficile infection; results from the observational study of risk factors for Clostridium difficile infection in hospitalized patients with infective diarrhea (ORCHID)","volume":"8","author":"Davies","year":"2020","journal-title":"Front Public Health"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2025.117184_bib0005","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1128\/AAC.00642-15","article-title":"Risk factors for acquisition and loss of Clostridium difficile colonization in hospitalized patients","volume":"59","author":"Dubberke","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13017-019-0228-3","article-title":"2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients","volume":"14","author":"Sartelli","year":"2019","journal-title":"World J Emerg Surg"},{"issue":"suppl_2","key":"10.1016\/j.diagmicrobio.2025.117184_bib0007","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/cid\/cis462","article-title":"Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin","volume":"55","author":"Cornely","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"suppl_2","key":"10.1016\/j.diagmicrobio.2025.117184_bib0008","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/cid\/cis356","article-title":"Predictors of first recurrence of Clostridium difficile infection: implications for initial management","volume":"55","author":"Eyre","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06147-y","article-title":"Burden of Clostridioides difficile infection (CDI)-a systematic review of the epidemiology of primary and recurrent CDI","volume":"21","author":"Finn","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jiac.2019.07.005","article-title":"Fidaxomicin compared with vancomycin and metronidazole for the treatment of clostridioides (Clostridium) difficile infection: a network meta-analysis","volume":"26","author":"Okumura","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0011","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for clostridioides difficile infection in adults","volume":"27","author":"van Prehn","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0012","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.anaerobe.2018.11.005","article-title":"Effects of sub-minimal inhibitory concentrations of antibiotics on the morphology and surface hydrophobicity of periodontopathic anaerobes","volume":"55","author":"Lee","year":"2019","journal-title":"Anaerobe"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2025.117184_bib0013","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrmicro3270","article-title":"Microbiological effects of sublethal levels of antibiotics","volume":"12","author":"Andersson","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0014","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fmicb.2013.00020","article-title":"Concentration-dependent activity of antibiotics in natural environments","volume":"4","author":"Bernier","year":"2013","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.117184_bib0015","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/jam.13368","article-title":"Effect of antibiotics on biofilm inhibition and induction measured by real-time cell analysis","volume":"122","author":"Ferrer","year":"2017","journal-title":"J Appl Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-14-29","article-title":"Prevention of Clostridium difficilespore formation by sub-inhibitory concentrations of tigecycline and piperacillin\/tazobactam","volume":"14","author":"Garneau","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2025.117184_bib0017","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jiac.2020.02.014","article-title":"Inhibitory effect of fidaxomicin on biofilm formation in Clostridioides difficile","volume":"26","author":"Hamada","year":"2020","journal-title":"J Infect Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.117184_bib0018","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/antibiotics11050624","article-title":"Impact of subinhibitory concentrations of metronidazole on morphology, motility, biofilm formation and colonization of clostridioides difficile","volume":"11","author":"Doan","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2019.102113","article-title":"Coexistence of clostridioides difficile and Staphylococcus aureus in gut of Iranian outpatients with underlying inflammatory bowel disease","volume":"61","author":"Azimirad","year":"2020","journal-title":"Anaerobe"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.anaerobe.2017.05.004","article-title":"Molecular typing of Clostridium difficile isolates cultured from patient stool samples and gastroenterological medical devices in a single Iranian hospital","volume":"47","author":"Azimirad","year":"2017","journal-title":"Anaerobe"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0021","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1080\/22221751.2020.1780949","article-title":"Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study","volume":"9","author":"Azimirad","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0022","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2019"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0023","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0, 2025. https:\/\/www.eucast.org."},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.117184_bib0024","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1099\/jmm.0.000580","article-title":"Fidaxomicin reduces early toxin A and B production and sporulation in Clostridium difficilein vitro","volume":"66","author":"Aldape","year":"2017","journal-title":"J Med Microbiol"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.117184_bib0025","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s10096-019-03635-7","article-title":"Fructooligosaccharides and mannose affect Clostridium difficile adhesion and biofilm formation in a concentration-dependent manner","volume":"38","author":"Piotrowski","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106450","article-title":"Clostridioides difficile PCR ribotypes 001 and 084 can trigger autophagy process in human intestinal Caco-2 cells","volume":"185","author":"Azimirad","year":"2023","journal-title":"Microb Pathog"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0027","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/dku325","article-title":"Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile","volume":"70","author":"Aldape","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-04975-5","article-title":"Inhibitory effects of levilactobacillus brevis IBRC-M10790 on apoptosis and inflammation induced by clostridioides difficile culture supernatant in vitro","volume":"15","author":"Azimirad","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0029","article-title":"In-depth characterization of accessory gene regulator loci and associated virulence factors in tcdA+B+ Clostridioides difficile isolates","volume":"9","author":"Kodori","year":"2025","journal-title":"Curr Res Microb Sci"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fmicb.2018.00646","article-title":"Clostridium difficile - from colonization to infection","volume":"9","author":"Sch\u00e4ffler","year":"2018","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.117184_bib0031","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jhin.2018.01.015","article-title":"Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies","volume":"99","author":"Ofori","year":"2018","journal-title":"J Hosp Infect"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0032","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40168-016-0198-6","article-title":"Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk","volume":"4","author":"Davis","year":"2016","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0033","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.1038\/srep07485","article-title":"Impacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children","volume":"4","author":"Ling","year":"2014","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.117184_bib0034","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/toxins14050305","article-title":"An update on clostridioides difficile binary toxin","volume":"14","author":"Mart\u00ednez-Mel\u00e9ndez","year":"2022","journal-title":"Toxins"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2025.117184_bib0035","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1099\/jmm.0.05387-0","article-title":"Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile","volume":"52","author":"Drummond","year":"2003","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0036","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/imr.12567","article-title":"Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease","volume":"279","author":"Pickard","year":"2017","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2012.01.004","article-title":"Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence","volume":"40","author":"Vardakas","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.117184_bib0038","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12223-017-0582-z","article-title":"Alterations of growth rate and gene expression levels of UPEC by antibiotics at sub-MIC","volume":"63","author":"G\u00fcm\u00fc\u015f","year":"2018","journal-title":"Folia Microbiol (Praha)"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0039","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12879-018-3088-7","article-title":"Sub-inhibitory concentrations of oxacillin modify the expression of agr locus in Staphylococcus aureus clinical strains belonging to different clonal complexes","volume":"18","author":"Viedma","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bjid.2019.01.004","article-title":"Effects of sub-minimum inhibitory concentrations of ciprofloxacin on biofilm formation and virulence factors of Escherichia coli","volume":"23","author":"Dong","year":"2019","journal-title":"Braz J Infect Dis"},{"issue":"Pt 12","key":"10.1016\/j.diagmicrobio.2025.117184_bib0041","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1099\/jmm.0.05387-0","article-title":"Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile","volume":"52","author":"Drummond","year":"2003","journal-title":"J Med Microbiol"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.117184_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241903","article-title":"Impact of subinhibitory concentrations of metronidazole on proteome of clostridioides difficile strains with different levels of susceptibility","volume":"15","author":"Doan","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0043","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s10096-020-03857-0","article-title":"The effect of berberine chloride and\/or its combination with vancomycin on the growth, biofilm formation, and motility of clostridioides difficile","volume":"39","author":"Wulta\u0144ska","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2025.117184_bib0044","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1128\/AAC.01582-06","article-title":"Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the cecal contents of mice","volume":"51","author":"Adams","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2025.117184_bib0045","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1099\/jmm.0.47739-0","article-title":"Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile","volume":"57","author":"Gerber","year":"2008","journal-title":"J Med Microbiol"},{"issue":"8325","key":"10.1016\/j.diagmicrobio.2025.117184_bib0046","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0140-6736(83)91832-9","article-title":"Stimulation of enterotoxin production of Clostridium difficile by antibiotics","volume":"321","author":"Honda","year":"1983","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.117184_bib0047","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/aem.38.4.637-641.1979","article-title":"Effect of environmental stress on Clostridium difficile toxin levels during continuous cultivation","volume":"38","author":"Onderdonk","year":"1979","journal-title":"Appl Environ Microbiol"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2025.117184_bib0048","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1128\/AAC.49.8.3529-3532.2005","article-title":"Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice","volume":"49","author":"Pultz","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0049","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/dku325","article-title":"Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile","volume":"70","author":"Aldape","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.micpath.2017.03.002","article-title":"Toxin production of Clostridium difficile in sub-MIC of vancomycin and clindamycin alone and in combination with ceftazidime","volume":"107","author":"Zarandi","year":"2017","journal-title":"Microb Pathog"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0051","first-page":"18","article-title":"Toxin A and B genes expression of Clostridium difficile in the sub-minimum inhibitory concentration of clindamycin, vancomycin and in combination with ceftazidime","volume":"12","author":"Moradi","year":"2020","journal-title":"Iran J Microbiol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.117184_bib0052","article-title":"Spore production of toxigenic and non-toxigenic Clostridium difficile isolates in sub-MIC of Vancomycin, Clindamycin, and ceftazidime","volume":"12","author":"Zarandi","year":"2019","journal-title":"Jundishapur J Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.117184_bib0053","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.TBS-0010-2012","article-title":"Physiology and sporulation in Clostridium","volume":"2","author":"D\u00fcrre","year":"2014","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0054","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.anaerobe.2016.04.010","article-title":"Sporulation properties and antimicrobial susceptibility in endemic and rare Clostridium difficile PCR ribotypes","volume":"39","author":"Zidaric","year":"2016","journal-title":"Anaerobe"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.117184_bib0055","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/jac\/dkp042","article-title":"Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model","volume":"63","author":"Ochsner","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2025.117184_bib0056","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1093\/cid\/cis453","article-title":"Fidaxomicin inhibits spore production in Clostridium difficile","volume":"55 Suppl 2","author":"Babakhani","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2013.62","article-title":"Clostridium difficile infection in the twenty-first century","volume":"2","author":"Ghose","year":"2013","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.117184_bib0058","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.mimet.2007.05.021","article-title":"The ClosTron: a universal gene knock-out system for the genus Clostridium","volume":"70","author":"Heap","year":"2007","journal-title":"J Microbiol Methods"},{"issue":"19","key":"10.1016\/j.diagmicrobio.2025.117184_bib0059","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1128\/JB.00326-11","article-title":"Localization of the Clostridium difficile cysteine protease Cwp84 and insights into its maturation process","volume":"193","author":"Chapet\u00f3nMontes","year":"2011","journal-title":"J Bacteriol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2025.117184_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158204","article-title":"Deciphering adaptation strategies of the epidemic Clostridium difficile 027 strain during infection through in vivo transcriptional analysis","volume":"11","author":"Kansau","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0061","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760220035","article-title":"Binding of the extracellular matrix laminin-1 to clostridioides difficile strains","volume":"117","author":"Santos","year":"2022","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.117184_bib0062","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1128\/IAI.70.10.5770-5778.2002","article-title":"Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues","volume":"70","author":"Calabi","year":"2002","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.117184_bib0063","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1128\/JCM.43.10.5018-5025.2005","article-title":"Variability of Clostridium difficile surface proteins and specific serum antibody response in patients with Clostridium difficile-associated disease","volume":"43","author":"P\u00e9chin\u00e9","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.117184_bib0064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078404","article-title":"Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficile","volume":"8","author":"Merrigan","year":"2013","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.117184_bib0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0882-4010(92)90037-O","article-title":"Purification and characterization of an immunodominant 36 kDa antigen present on the cell surface of Clostridium difficile","volume":"13","author":"Cerquetti","year":"1992","journal-title":"Microb Pathog"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.117184_bib0066","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11050624","article-title":"Impact of subinhibitory concentrations of metronidazole on morphology, motility, biofilm formation and colonization of clostridioides difficile","volume":"11","author":"Doan","year":"2022","journal-title":"Antibiot"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2025.117184_bib0067","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1128\/AAC.00532-09","article-title":"Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains","volume":"53","author":"Den\u00e8ve","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.117184_bib0068","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.micpath.2017.08.034","article-title":"Effect of sub-MIC of vancomycin and clindamycin alone and in combination with ceftazidime on Clostridium difficile surface layer protein A (slpA) gene expression","volume":"111","author":"Zarandi","year":"2017","journal-title":"Microb Pathog"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2025.117184_bib0069","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1099\/jmm.0.47676-0","article-title":"Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression","volume":"57","author":"Deneve","year":"2008","journal-title":"J Med Microbiol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2025.117184_bib0070","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1128\/JCM.02115-14","article-title":"Phenotypic and genotypic analysis of Clostridium difficile isolates: a single-center study","volume":"52","author":"Zhou","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0071","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1080\/22221751.2022.2105260","article-title":"Low-toxin clostridioides difficile RT027 strains exhibit robust virulence","volume":"11","author":"Anwar","year":"2022","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.117184_bib0072","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/22221751.2021.1900748","article-title":"New ribotype clostridioides difficile from ST11 group revealed higher pathogenic ability than RT078","volume":"10","author":"Gu","year":"2021","journal-title":"Emerg Microbes Infect"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2025.117184_bib0073","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00919-21","article-title":"c-di-GMP inhibits early sporulation in clostridioides difficile","volume":"6","author":"Edwards","year":"2021","journal-title":"mSphere"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.117184_bib0074","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00551-15","article-title":"Defining the roles of TcdA and TcdB in localized gastrointestinal disease, systemic organ damage, and the host response during Clostridium difficile infections","volume":"6","author":"Carter","year":"2015","journal-title":"mBio"},{"issue":"suppl_2","key":"10.1016\/j.diagmicrobio.2025.117184_bib0075","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1093\/cid\/cis453","article-title":"Fidaxomicin inhibits spore production in Clostridium difficile","volume":"55","author":"Babakhani","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325005061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325005061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:03:09Z","timestamp":1769518989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889325005061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0732889325005061"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.117184","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of sub-minimum inhibitory concentrations of metronidazole, vancomycin, and fidaxomicin on growth rate and virulence of Clostridioides difficile","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.117184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117184"}}